May 20, 2020
TYME Announces Fourth Quarter and Fiscal Year 2020 Financial and Operating Results
TYME-88-Panc pivotal trial enrolling patients using oral SM-88 as a potential treatment for third-line pancreatic cancer PanCAN enrolling patients in…